3 not yet recruiting, 1 active not recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 3, Active not recruiting 1 |
Follow Inotuzumab Ozogamicin (IO): new trials by email Literature Review of Inotuzumab Ozogamicin (IO) trials Research Report on Inotuzumab Ozogamicin (IO)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inotuzumab as Post-Trasplantation Therapy for Adult High-risk B-cell Precursor Acute Lymphoblastic Leukemia Inotuzumab Ozogamicin (IO) - Acute Lymphobkastic Leukemia, Adult | Phase 2 | Not yet recruiting | PETHEMA Foundation | 30 | 2026-10-30 | 2026-10-07 |
| Immunotargeted Therapy Plus Low-Dose Chemotherapy in Newly Diagnosed Adult Ph+ B-ALL olverembatinib, Venetoclax, Inotuzumab Ozogamicin (IO) - Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) | Phase 2 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 22 | 2026-10-12 | 2026-09-25 |
| Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial Inotuzumab Ozogamicin (IO), Venetoclax, Blinatumomab - Ph- Acute Lymphoblastic Leukemia (Ph-ALL) | Phase 2 | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 32 | 2026-06-12 | 2026-06-11 |
| Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia Inotuzumab Ozogamicin (IO) - Acute Lymphoid Leukemia | Phase 2 | Active not recruiting | Gruppo Italiano Malattie EMatologiche dell'Adulto | 76 | 2019-10-30 | 2026-07-16 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
Institute of Hematology & Blood Diseases Hospital, China (2) · Gruppo Italiano Malattie EMatologiche dell'Adulto (1) · PETHEMA Foundation (1)
China (1) · Italy (1) · Spain (1)
Fabio Ciceri (1) · Giovanni Martinelli (1)
2018 (1)